Clinical Trial Update: To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and efficacy of Liquid ROTAVAC 5C vaccine for childhood diarrhea caused by rotavirus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Liquid ROTAVAC 5C (ROTAVAC 5C)

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Rotavirus Gastroenteritis | Phase 3 | Status: COMPLETED